Company-wide revenue
Reported revenue in 2021 ¥868.87B Reported revenue in 2025 ¥1.01T
- growth amount
- +¥141.81B
- growth annualized
- +3.9%
- growth total
- +16.3%
Japanese company profile · 7733
OLYMPUS CORPORATION
In its FY2025 public filing, OLYMPUS CORPORATION reports Gastroenterology solution, Surgical intervention. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: オリンパス株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
OLYMPUS CORPORATION's largest reported business by revenue in FY2025 was Gastroenterology solution.
The business with the highest reported segment profit in FY2025 was Gastroenterology solution.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Segment profit (loss) |
|---|---|---|---|
| Gastroenterology solution | ¥697.36B ↗ | 69.0% | ¥136.36B ↗ |
| Surgical intervention | ¥313.11B ↗ | 31.0% | −¥14.99B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Gastroenterology solution
- 消化器内視鏡ソリューション
- Surgical intervention
- サージカルインターベンション
- Business label unavailable in English
- 内視鏡
- Business label unavailable in English
- 治療機器
- Science
- 科学
- Sales
- 売上高
- Segment profit (loss)
- セグメント利益（損失）
Original Japanese label
- Gastroenterology solution
- 消化器内視鏡ソリューション
- Surgical intervention
- サージカルインターベンション
- Business label unavailable in English
- 内視鏡
- Business label unavailable in English
- 治療機器
- Science
- 科学
- Sales
- 売上高
- Segment profit (loss)
- セグメント利益（損失）
What is growing?
What is growing?
Business revenue growth
Business label unavailable in English
Reported revenue in 2021 ¥461.55B Reported revenue in 2024 ¥636.3B
- growth amount
- +¥174.75B
- growth annualized
- +11.3%
- growth total
- +37.9%
View original filing
Business label unavailable in English
Reported revenue in 2021 ¥275.59B Reported revenue in 2024 ¥360.69B
- growth amount
- +¥85.1B
- growth annualized
- +9.4%
- growth total
- +30.9%
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YDN3
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.